Readily Raises $11M Series A for Healthcare Compliance AI
Define Ventures leads Readily's $11M Series A as the healthcare compliance platform connects regulatory changes with owners, actions and audit evidence.
Venture Capital News & Analysis
Funding news, venture capital analysis, investor profiles, and market intelligence.
-
-
Altay Therapeutics Closes $37M Series A for an Oral FSHD Drug
Sound Bioventures and HealthCap co-lead Altay's $37M Series A, backing investigational DUX4 inhibitor DX5057 ahead of planned human testing in 2027.
-
Reach Security Raises $50M-Plus Series B to Operate Existing Cyber Defenses
Top Tier Capital Partners leads a Series B exceeding $50M as Reach shifts security-control validation into APIs, MCP and operational workflows.
-
SUNMMIO Closes Pre-A2 and Series A; Nearly RMB2B Is Yearly Funding
SUNMMIO completed Pre-A2 and Series A financing led by Beijing state-backed platforms. Latest amounts are undisclosed; nearly RMB2B is cumulative funding over one year.
-
Pluto Security Emerges With $42M Across Seed and Series A
Pluto Security disclosed about $42M across seed and Series A funding. Jump Capital says its Series A was $33M; media reports about $34M. VCT explains the discrepancy.
-
Soufflé Therapeutics Closes $135M Series B for RNA Delivery Beyond the Liver
Juvia Group led Soufflé Therapeutics' $135M Series B. The funding advances cell-targeted RNA medicines, where delivery and human data—not payload design alone—drive value.